Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137. - Zerva A; Raig ND; Zhuang Z; Krämer A; Dopfer J; Togashi R; Schwalm MP; Elson L; Frischkorn JM; Berger BT; Müller S; Chen JK; et al. (BioRxiv : the preprint server for biology, 2026)